Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Pfizer Global Medical Grants
UM Funding ID
FD03510
Sponsor
Pfizer Global Medical Grants
Category
Canadian Funding Opportunities
Description
This competitive grant program seeks to support quality Improvement (QI) initiatives to increase the capacity of the health care system to provide more timely suspicion, identification and diagnosis and appropriate treatment for ATTR-CM patients.
Individual projects requesting up to CAD $50,000 will be considered. Pfizer anticipates funding 2 projects.
VPRI Contact
Holly Musto
Research Contract CoordinatorHolly [dot] .Musto [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 22-May-2024 4:30 pm CST | 31-May-2024 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.